Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
5.6%
% of FHLC's 399 holdings also in PJP
91.7%
% of PJP's 24 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.7% | 6.7% | 6.7% |
|
JOHNSON & JOHNSON | 6.6% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 4.7% | 6.0% | 4.7% |
|
ABBVIE INC | 4.4% | 5.9% | 4.4% |
|
ABBOTT LABORATORIES | 3.2% | 6.1% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 9.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
DANAHER CORP | 2.8% |
|
ANTHEM INC | 2.1% |
|
INTUITIVE SURGICAL INC | 2.0% |
|
ELI LILLY & CO | 1.9% |
 |
MEDTRONIC PLC | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% |
|
STRYKER CORP | 1.8% |
|
VERTEX PHARMACEUTICALS INC | 1.6% |
FHLC Underweight Relative to PJP
|
GILEAD SCIENCES INC | -4.5% |
|
AMPHASTAR PHARMACEUTICALS INC | -3.9% |
|
AMGEN INC | -3.9% |
 |
TARO PHARMACEUTICAL INDUS | -3.8% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
LIGAND PHARMACEUTICALS-CL B | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
|
GERON CORP | -3.2% |
 |
VALEANT PHARMACEUTICALS INT'L | -3.1% |